Franklin Resources’s Upstream Bio Inc UPB Stock Holding History

Franklin Resources’s Portfolio UPB Stock Details UPB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,589	Closed	-$131K	–	3351
2026 Q1	$131K	Buy	+14,589	New	+$262K	﹤0.01%	2877

Other funds holding UPB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources's UPB Position: Q2 2026 in Review

Franklin Resources sold out of Upstream Bio Inc (UPB) in Q2 2026, closing a stake of 14,589 shares — an estimated $131K sold.

Franklin Resources first reported a position in UPB in Q1 2026 and held it in 1 quarter. The position peaked at $131K in Q1 2026. 149 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

Franklin Resources reported no remaining Upstream Bio Inc position as of Q2 2026 after selling out during the quarter.
Franklin Resources sold 14,589 Upstream Bio Inc shares in Q2 2026, an estimated $131K.
Franklin Resources first reported a position in Upstream Bio Inc in Q1 2026 and held it in 1 quarter.
Franklin Resources's Upstream Bio Inc position peaked at $131K in Q1 2026.
149 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.